GB922600A - Ortho-tertiary-butyl phenolethers - Google Patents
Ortho-tertiary-butyl phenolethersInfo
- Publication number
- GB922600A GB922600A GB16171/60A GB1617160A GB922600A GB 922600 A GB922600 A GB 922600A GB 16171/60 A GB16171/60 A GB 16171/60A GB 1617160 A GB1617160 A GB 1617160A GB 922600 A GB922600 A GB 922600A
- Authority
- GB
- United Kingdom
- Prior art keywords
- butyl
- tert
- methyl
- phenol
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention comprises ortho tert. butyl ethylamines of the general formula <FORM:0922600/IV(a)/1> where R1 and R2, which may be the same or different, represent a hydrogen atom or an alkyl group containing 1-4 carbon atoms or a phenethyl group, or R1 and R2 together with a nitrogen atom form a heterocyclic ring, R3 represents a hydrogen atom or an alkyl group containing 1-4 carbon atoms, R4 and R5 may be a hydrogen or an alkyl group containing 1-4 carbon atoms or an alkoxy, hydroxy, amino or acylamino group, together with the acid addition salts and quaternary compounds derived by quaternisation with a compound R6X where R6 represents an alkyl group and X represents the anion associated with the quaternary compound. The compounds may be prepared by (1) reacting the substituted o-tert. butyl phenol with a b -dialkylamino alkyl halide, (2) by converting the phenol to the phenol ether containing a reactive group in the b -position, such as halo or p-toluene sulphonyloxy group, which is subsequently reacted with an alkyl or dialkyl-amine or (3) by converting the phenol to the a -cyanoalkyl ether which is subsequently reduced and the primary amino group converted to a secondary or tertiary amino group if desired. Examples describe the preparation of 2-(b -diethylaminoethoxy)-4-methyl-, 2-(b -aminoethoxy)-4-methyl-, 2-(b -phenethylaminoethoxy)- 4-methyl-, 4-acetamido-2-(b -diethylaminoethoxy)- and 2-(b -diethylaminoethoxy)- 4-hydroxytert. butyl benzene and 2-(2-t. butyl-5-methylphenoxy)-ethyl-triethylammonium iodide, 2-(b - phenethylamino-ethoxy)-4-methyl-tert. butyl benzene isethionate, 2-(2-t. butyl-5-hydroxy-4-methylphenoxy)- ethyl triethylammonium iodide, 2-(2-t. butyl-4-methoxy phenoxy) ethyl trimethylammonium isethionate and 2-(b -N-piperidino-ethoxy)-tert. butyl benzene citrate. A further list of compounds falling within the general formula is also given. The above compounds and their acid addition salts have central nervous depressant and analgesic properties while the quaternary salts have long-acting local anaesthetic and sympathetic nervous system blocking properties. The pharmacological properties are compared with those of pethidine and chloropromazine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB16171/60A GB922600A (en) | 1960-05-06 | 1960-05-06 | Ortho-tertiary-butyl phenolethers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB16171/60A GB922600A (en) | 1960-05-06 | 1960-05-06 | Ortho-tertiary-butyl phenolethers |
Publications (1)
Publication Number | Publication Date |
---|---|
GB922600A true GB922600A (en) | 1963-04-03 |
Family
ID=10072459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB16171/60A Expired GB922600A (en) | 1960-05-06 | 1960-05-06 | Ortho-tertiary-butyl phenolethers |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB922600A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3408387A (en) * | 1964-09-30 | 1968-10-29 | Ici Ltd | Amidoaroxyalkanolamines |
EP0062596A1 (en) * | 1981-04-06 | 1982-10-13 | Cortial S.A. | Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines |
EP0269363A2 (en) * | 1986-11-21 | 1988-06-01 | A/S Cheminova | Amino-alkylated hydroxy compounds and their use as fungicides |
WO2003011210A2 (en) * | 2001-07-31 | 2003-02-13 | Astrazeneca Ab | Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
US6887871B2 (en) | 2000-02-23 | 2005-05-03 | Astrazeneca Ab | Use of phenylheteroakylamine derivatives |
US6900243B2 (en) | 2000-02-23 | 2005-05-31 | Astrazeneca Ab | Phenylheteroalkylamine derivatives |
US6953797B2 (en) | 2000-02-23 | 2005-10-11 | Astrazeneca Ab | Use of phenylheteroalkylamine derivatives |
-
1960
- 1960-05-06 GB GB16171/60A patent/GB922600A/en not_active Expired
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3408387A (en) * | 1964-09-30 | 1968-10-29 | Ici Ltd | Amidoaroxyalkanolamines |
EP0062596A1 (en) * | 1981-04-06 | 1982-10-13 | Cortial S.A. | Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines |
EP0269363A2 (en) * | 1986-11-21 | 1988-06-01 | A/S Cheminova | Amino-alkylated hydroxy compounds and their use as fungicides |
WO1988003756A1 (en) * | 1986-11-21 | 1988-06-02 | A/S Cheminova | Amino-alkylated hydroxy compounds and their use as fungicides |
EP0269363A3 (en) * | 1986-11-21 | 1989-11-23 | A/S Cheminova | Amino-alkylated hydroxy compounds and their use as fungicides |
US6887871B2 (en) | 2000-02-23 | 2005-05-03 | Astrazeneca Ab | Use of phenylheteroakylamine derivatives |
US6900243B2 (en) | 2000-02-23 | 2005-05-31 | Astrazeneca Ab | Phenylheteroalkylamine derivatives |
US6953797B2 (en) | 2000-02-23 | 2005-10-11 | Astrazeneca Ab | Use of phenylheteroalkylamine derivatives |
WO2003011210A2 (en) * | 2001-07-31 | 2003-02-13 | Astrazeneca Ab | Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
US7223794B2 (en) | 2001-07-31 | 2007-05-29 | Astrazeneca Ab | Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
WO2003011210A3 (en) * | 2001-07-31 | 2007-10-25 | Astrazeneca Ab | Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1166818A (en) | N-Hydroxyamides of Substituted Phenylacetic Acids, Salts thereof and their preparation | |
GB922600A (en) | Ortho-tertiary-butyl phenolethers | |
GB1392674A (en) | Dopamine derivatives | |
GB1062713A (en) | 4'-hydroxy-4'-piperidyl-ketones | |
GB830709A (en) | Improvements in or relating to piperidine-carboxamide derivatives | |
GB1108040A (en) | Derivatives of oripavine and thebaine | |
GB945068A (en) | Fungicidal and bactericidal compositions | |
ES463783A1 (en) | Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them | |
GB1144039A (en) | New naphthyl- and tetrahydronaphthyl-formamidines | |
ES334038A1 (en) | Procedure for preparing a quaternary ammonium halide. (Machine-translation by Google Translate, not legally binding) | |
GB823191A (en) | New phenthiazine derivatives and processes for their preparation | |
GB984119A (en) | Substituted piperidines and methods for their preparation | |
GB1528862A (en) | 1,4-disubstituted piperazine derivatives and process for their preparation | |
GB1014918A (en) | 3-(3-hydroxyphenyl)-1-phenacyl-piperidine compounds and their preparation | |
GB959993A (en) | Camphor derivatives | |
GB996485A (en) | Aminoketone derivatives | |
GB1272134A (en) | Process for the manufacture of aryloxazoles | |
ES477709A1 (en) | Benzothiazepines | |
ES250754A1 (en) | Acyl-and amino-substituted phenol ethers | |
SE325278B (en) | ||
ES275437A1 (en) | Amino-alkylidene-dibenzocycloheptene derivatives | |
GB1223889A (en) | Process for the preparation of aziridine derivatives | |
ES260288A2 (en) | Process for the preparation of boric phenthiazines | |
GB1038240A (en) | New acenaphthenes and process for preparing same | |
GB1142610A (en) | Ketoxime ethers |